Trexquant Investment’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-11,013
| Closed | -$176K | – | 1613 |
|
2021
Q2 | $176K | Sell |
11,013
-5,463
| -33% | -$87.3K | 0.01% | 942 |
|
2021
Q1 | $294K | Buy |
16,476
+5,103
| +45% | +$91.1K | 0.03% | 765 |
|
2020
Q4 | $154K | Buy |
+11,373
| New | +$154K | 0.02% | 935 |
|
2020
Q1 | – | Sell |
-16,626
| Closed | -$402K | – | 1518 |
|
2019
Q4 | $402K | Buy |
+16,626
| New | +$402K | 0.02% | 644 |
|
2019
Q3 | – | Sell |
-15,005
| Closed | -$443K | – | 1190 |
|
2019
Q2 | $443K | Buy |
+15,005
| New | +$443K | 0.04% | 499 |
|
2018
Q3 | – | Sell |
-5,401
| Closed | -$365K | – | 1270 |
|
2018
Q2 | $365K | Sell |
5,401
-24,115
| -82% | -$1.63M | 0.03% | 626 |
|
2018
Q1 | $1.6M | Buy |
29,516
+25,422
| +621% | +$1.38M | 0.11% | 294 |
|
2017
Q4 | $245K | Buy |
+4,094
| New | +$245K | 0.03% | 836 |
|
2017
Q3 | – | Sell |
-7,700
| Closed | -$405K | – | 1102 |
|
2017
Q2 | $405K | Buy |
+7,700
| New | +$405K | 0.11% | 334 |
|
2017
Q1 | – | Sell |
-10,566
| Closed | -$400K | – | 1386 |
|
2016
Q4 | $400K | Buy |
10,566
+3,821
| +57% | +$145K | 0.06% | 535 |
|
2016
Q3 | $255K | Buy |
+6,745
| New | +$255K | 0.06% | 548 |
|
2015
Q4 | – | Sell |
-31,570
| Closed | -$560K | – | 1342 |
|
2015
Q3 | $560K | Buy |
+31,570
| New | +$560K | 0.05% | 679 |
|
2015
Q2 | – | Sell |
-20,100
| Closed | -$629K | – | 1314 |
|
2015
Q1 | $629K | Buy |
+20,100
| New | +$629K | 0.06% | 598 |
|